RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
Adjusted price
−4.53% total return, past year
Key statistics
- Market cap
- $6.4B
- P/E (TTM)
- —
- 52-week range
- $75.82$117.62
- Beta (5Y monthly)
- 2.01
- Median dollar volume
- $64.6M
- Shares outstanding
- 68.9M
- Revenue, last 12 months
- $240M
- Sector
- Consumer Discretionary
- First close
- Oct 9, 2017
Returns
Total
- 1M
- −11.9%
- YTD
- −13.3%
- 1Y
- −4.5%
Per year
- 3Y
- +61.3%
- 5Y
- +48.0%
- Since 2017
- +16.0%
Financials
Annual returns
2017 from Oct 9 · 2026 through Oct 2